Literature DB >> 29152908

The genetics of Kawasaki disease.

Yoshihiro Onouchi1.   

Abstract

Kawasaki disease (KD) is a complex disorder which affects genetically susceptible infants and children. Several susceptibility genes (e.g., ITPKC, CASP3, CD40 and ORAI) and chromosomal regions have been identified through genome-wide association and genome-wide linkage studies to have association with KD. Knowledge of susceptibility genes involved in the pathogenesis of KD may provide new insights into diagnosis and treatment of this condition. However, there is much that we still do not know about the genetic basis of KD.
© 2017 Asia Pacific League of Associations for Rheumatology and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  Kawasaki disease; genetic variants; susceptibility gene

Mesh:

Year:  2017        PMID: 29152908     DOI: 10.1111/1756-185X.13218

Source DB:  PubMed          Journal:  Int J Rheum Dis        ISSN: 1756-1841            Impact factor:   2.454


  39 in total

1.  Autoantibody discovery across monogenic, acquired, and COVID19-associated autoimmunity with scalable PhIP-Seq.

Authors:  Sara E Vazquez; Sabrina A Mann; Aaron Bodansky; Andrew F Kung; Zoe Quandt; Elise M N Ferré; Nils Landegren; Daniel Eriksson; Paul Bastard; Shen-Ying Zhang; Jamin Liu; Anthea Mitchell; Caleigh Mandel-Brehm; Brenda Miao; Gavin Sowa; Kelsey Zorn; Alice Y Chan; Chisato Shimizu; Adriana Tremoulet; Kara Lynch; Michael R Wilson; Olle Kampe; Kerry Dobbs; Ottavia M Delmonte; Luigi D Notarangelo; Jane C Burns; Jean-Laurent Casanova; Michail S Lionakis; Troy R Torgerson; Mark S Anderson; Joseph L DeRisi
Journal:  bioRxiv       Date:  2022-03-24

2.  Delta-neutrophil index: a potential predictor of coronary artery involvement in Kawasaki disease by retrospective analysis.

Authors:  Sang Hun Lee; Kyung Ok Ko; Jae Woo Lim; Jung Min Yoon; Young Hwa Song; Jong Wook Lee; Eun Jung Cheon
Journal:  Rheumatol Int       Date:  2019-09-23       Impact factor: 2.631

3.  Socioeconomic and Racial and/or Ethnic Disparities in Multisystem Inflammatory Syndrome.

Authors:  Karina Javalkar; Victoria K Robson; Lukas Gaffney; Amy M Bohling; Puneeta Arya; Sarah Servattalab; Jordan E Roberts; Jeffrey I Campbell; Sepehr Sekhavat; Jane W Newburger; Sarah D de Ferranti; Annette L Baker; Pui Y Lee; Megan Day-Lewis; Emily Bucholz; Ryan Kobayashi; Mary Beth Son; Lauren A Henderson; John N Kheir; Kevin G Friedman; Audrey Dionne
Journal:  Pediatrics       Date:  2021-02-18       Impact factor: 7.124

4.  Increased Risk of Kawasaki Disease in Infants Born of Mothers With Immune Disorders.

Authors:  Hsiao-Wen Chu; Chien-Heng Lin; Ming-Chih Lin; Ya-Chi Hsu
Journal:  Front Pediatr       Date:  2021-05-14       Impact factor: 3.418

Review 5.  PIMS-TS, the New Paediatric Systemic Inflammatory Disease Related to Previous Exposure to SARS-CoV-2 Infection-"Rheumatic Fever" of the 21st Century?

Authors:  Violetta Opoka-Winiarska; Ewelina Grywalska; Jacek Roliński
Journal:  Int J Mol Sci       Date:  2021-04-26       Impact factor: 5.923

6.  In silico Identification of 10 Hub Genes and an miRNA-mRNA Regulatory Network in Acute Kawasaki Disease.

Authors:  Jin Ma; Huan Gui; Yunjia Tang; Yueyue Ding; Guanghui Qian; Mengjie Yang; Mei Wang; Xiudao Song; Haitao Lv
Journal:  Front Genet       Date:  2021-03-25       Impact factor: 4.599

Review 7.  Cytokine cascade in Kawasaki disease versus Kawasaki-like syndrome.

Authors:  M A Bordea; C Costache; A Grama; A I Florian; I Lupan; G Samasca; D Deleanu; P Makovicky; P Makovicky; K Rimarova
Journal:  Physiol Res       Date:  2022-01-19       Impact factor: 1.881

8.  SARS-CoV-2 infection triggering recurrence of Kawasaki disease in a 10-year-old child.

Authors:  Ashok Renganathan; Ankit Garg; Sona Chowdhary; Dinesh Raj
Journal:  BMJ Case Rep       Date:  2021-03-24

Review 9.  Perspective of Immunopathogenesis and Immunotherapies for Kawasaki Disease.

Authors:  Lung Chang; Horng-Woei Yang; Tang-Yu Lin; Kuender D Yang
Journal:  Front Pediatr       Date:  2021-07-19       Impact factor: 3.418

10.  Observation on the clinical effect of high-dose Intravenous Immunoglobulin combined with low-dose prednisone acetate in the treatment of patients with Kawasaki Disease.

Authors:  Hao Zhang; Mei-Ying Wang; Yong-Nan Teng; Xiao-Dan Wang; Hai-Tao Cao
Journal:  Pak J Med Sci       Date:  2021 Jul-Aug       Impact factor: 1.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.